All In MedTech

Device Trial Radar · NCT03887715

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 6,800 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

6,800

Planned (sponsor's estimate)

Start

Sep 26, 2019

Primary completion

Feb 28, 2028

Study completion Dec 31, 2030

Sponsor

Lead sponsor
LivaNovaPublic (LIVN)
Sponsor type
Industry
First posted
Mar 25, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Objectives of this study are to determine whether active VNS Therapy treatment is superior to a no stimulation control in producing a reduction in baseline depressive symptom severity, based on multiple depression scale assessment tools at 12 months from randomization.

Conditions

  • Treatment Resistant Depression

Interventions

  • Vagus Nerve Stimulation (VNS)Device

    VNS is an implantable device that delivers stimulation to the vagal nerve.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Montgomery Åsberg Depression Rating Scale (MADRS) Rate of ResponseTime frame: 12 months post randomization
  2. Montgomery Åsberg Depression Rating Scale (MADRS) Time to First responseTime frame: Baseline up to 12 Months
  3. Montgomery Åsberg Depression Rating Scale (MADRS) Time to First RemissionTime frame: Baseline up to 12 Months

10 more outcomes with a free account

Locations

101 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama · Recruiting

  • UAB Huntsville Regional Medical Center

    Huntsville, Alabama · Recruiting

  • Access Multi Specialty Medical Clinic, Inc

    Burlingame, California · Terminated

98 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.